![]() |
市場調査レポート
商品コード
1753883
脳モニタリング市場レポート:製品タイプ、処置、用途、エンドユーザー、地域別、2025-2033年Brain Monitoring Market Report by Product Type, Procedure, Application, End User, and Region 2025-2033 |
||||||
カスタマイズ可能
|
脳モニタリング市場レポート:製品タイプ、処置、用途、エンドユーザー、地域別、2025-2033年 |
出版日: 2025年06月02日
発行: IMARC
ページ情報: 英文 138 Pages
納期: 2~3営業日
|
世界の脳モニタリング市場規模は2024年に68億米ドルに達しました。今後、同市場は2033年までに111億米ドルに達し、2025年から2033年にかけて5.6%の成長率(CAGR)を示すと予測されています。神経疾患の増加、脳モニタリングデバイスの技術進歩、脳の健康への注目の高まり、高齢化が主に市場成長を牽引しています。
神経疾患の有病率の上昇
神経疾患の有病率の上昇は、脳モニタリング市場の成長に影響を与える重要な要因です。世界中の人口が高齢化するにつれて、アルツハイマー病やパーキンソン病などの加齢に関連する神経疾患の発生率が増加しています。例えば、国立医学図書館が発表した論文によると、高齢化により、アルツハイマー病、原発性悪性脳腫瘍、パーキンソン病、筋萎縮性側索硬化症など、さまざまな神経疾患の社会的負担が大幅に増加しています。さらに、世界保健機関(WHO)によると、60歳以上の成人の14%近くが精神障害を抱えて生活しています。これとは別に、神経障害がより一般的になるにつれて、これらの状態を正確に検出し、監視するための高度な診断ツールの必要性が高まっています。EEG(脳波計)、MRI(磁気共鳴画像装置)、PET(陽電子放射断層撮影)スキャンなどの脳モニタリング技術は、神経疾患の診断と評価において重要な役割を果たしています。例えば、2024年4月、非侵襲的脳刺激および相乗的モニタリング技術を提供するSoterix Medical Inc.は、独自の紐なし設計の高精細経頭蓋電気刺激(HD-tES)およびEEGシステムであるMxN-GO EEGを発売しました。この技術は、移動中や自然環境下での脳活動の電気刺激やモニタリングを必要とする研究用途向けに設計されています。これらの要因が市場成長をさらに促進しています。
脳波(EEG)アプリケーションの増加
脳波(EEG)アプリケーションの増加は、脳モニタリング市場の成長を大きく促進しています。EEGは、てんかん、睡眠障害、脳腫瘍などさまざまな神経疾患の診断に不可欠です。脳内の異常な電気活動を検出するその能力は、正確な診断、治療方針の決定、患者の転帰の改善に役立ちます。例えば、2022年7月、米国国立衛生研究所が米国内の病院を対象に行った調査によると、EEG装置を使用することで、医師による電撃発作診断が劇的に向上することが判明しました。臨床診断と比較した場合、脳波診断の感度は77.8%から100%に、特異度は63.9%から89%に上昇しました。高密度脳波計、ポータブル機器、信号処理技術の向上など、脳波技術の絶え間ない進歩が、その診断能力と有用性を高めています。例えば、2024年4月、NeuroVigil社は米国で個人用脳モニターiBrainを発表しました。iBrainは、脳の電気活動を評価し神経学的異常を検出するために日常的に使用されている脳波(EEG)技術に基づいています。患者は、自宅や睡眠中にこのガジェットを使用して、より効率的かつ簡単に脳波データを取得することができます。このような技術的改善により、EEGは多様なヘルスケア環境においてより利用しやすく信頼できるものとなり、より広範な普及と市場拡大を促進しています。これらの要因が脳モニタリング市場シェアにさらに貢献しています。
新たな神経科学調査
神経科学研究の増加が脳モニタリング市場の成長に寄与しています。神経科学の研究は、MRI(磁気共鳴画像法)、PET(陽電子放射断層撮影法)、CT(コンピュータ断層撮影法)、EEG(脳波計)などの脳画像技術の限界を絶えず押し広げています。例えば、GEヘルスケアは2024年5月、最先端の頭部専用MRIスキャナー「SIGNA MAGNUS」を発表しました。SIGNA MAGNUSは、科学者に脳の複雑な構造を深く調べるための強力な機器を与える大きな進歩です。これらの技術は、健常者と神経疾患患者の両方における脳の構造、機能、結合性を視覚化し、理解するために極めて重要です。このほか、神経科学研究では、大規模な脳画像や脳波データを分析するために、AIや機械学習アルゴリズムを活用するケースが増えています。これらの高度な分析ツールは、複雑な脳活動パターンの解釈を強化し、微妙なバイオマーカーを特定し、疾患の進行を予測します。また、より良い診断を提供するために、様々な組織が脳疾患における人工知能の応用を推進しています。例えば、2024年2月には、アルツハイマー病、パーキンソン病、その他の神経疾患との闘いにおける人工知能(AI)の倫理的応用を推進するために、独立非営利団体である10,000 Brains Projectが発足しました。同団体の目的は、より良い診断と治療を必要とする患者のために、研究者がこの強力な新技術を迅速に導入できるよう、必要な指導力、経験、資金援助を提供することです。このような要因が市場の需要をさらに高めています。
The global brain monitoring market size reached USD 6.8 Billion in 2024. Looking forward, the market is expected to reach USD 11.1 Billion by 2033, exhibiting a growth rate (CAGR) of 5.6% during 2025-2033. Growing incidences of neurological disorders, technological advancements in brain monitoring devices, surging focus on brain health, and aging population are primarily driving the market growth.
Rising Prevalence of Neurological Disorders
The rising prevalence of neurological disorders is a significant factor influencing the growth of the brain monitoring market. As populations around the world age, the incidence of age-related neurological disorders such as Alzheimer's disease and Parkinson's disease increases. For instance, according to an article published by the National Library of Medicine, the aging population has significantly increased the societal burden of various neurologic illnesses, including Alzheimer's disease, primary malignant brain tumors, Parkinson's disease, and amyotrophic lateral sclerosis. Moreover, according to the World Health Organization (WHO), nearly 14% of adults aged 60 and above live with a mental disorder. Apart from this, as neurological disorders become more prevalent, there is a growing need for advanced diagnostic tools to accurately detect and monitor these conditions. Brain monitoring technologies such as EEG (electroencephalography), MRI (magnetic resonance imaging), and PET (positron emission tomography) scans play a crucial role in the diagnosis and assessment of neurological disorders. For instance, in April 2024, Soterix Medical Inc., a non-invasive brain stimulation and synergistic monitoring technologies provider, launched MxN-GO EEG, a high-definition transcranial Electrical Stimulation (HD-tES) and EEG system with a unique untethered design. The technology is designed for research applications that need electrical stimulation and monitoring of brain activity in mobile and natural settings. These factors are further proliferating the market growth.
Increasing Application of Electroencephalography (EEG)
The increasing application of Electroencephalography (EEG) is significantly driving the growth in the brain monitoring market. EEG is essential for diagnosing various neurological disorders such as epilepsy, sleep disorders, and brain tumors. Its ability to detect abnormal electrical activity in the brain helps in accurate diagnosis, guiding treatment decisions and improving patient outcomes. For instance, in July 2022, the National Institute of Health performed a survey of hospitals in the United States and discovered that using EEG equipment dramatically improved electrographic seizure diagnosis by physicians. The sensitivity of electrographic seizure diagnosis increased from 77.8% to 100%, while the specificity increased from 63.9% to 89% when compared to clinical diagnosis. Continuous advancements in EEG technology, such as high-density EEG, portable devices, and improved signal processing techniques, enhance its diagnostic capabilities and usability. For instance, in April 2024, NeuroVigil introduced the iBrain personal brain monitor in the United States, which is an investigational portable gadget that can non-invasively record electrical activity in persons with neurological problems. iBrain is based on electroencephalogram (EEG) technology, which is routinely used to assess brain electrical activity and detect neurological abnormalities. Patients can use the gadget at home and during sleep to acquire EEG data more efficiently and easily. These technological improvements make EEG more accessible and reliable across diverse healthcare settings, fostering broader adoption and market expansion. These factors are further contributing to the brain monitoring market share.
Emerging Neuroscience Research
Increasing neuroscience research is contributing to the growth of the brain monitoring market. Research in neuroscience continually pushes the boundaries of brain imaging technologies such as MRI (Magnetic Resonance Imaging), PET (Positron Emission Tomography), CT (Computed Tomography), and EEG (Electroencephalography). For instance, in May 2024, GE HealthCare unveiled SIGNA MAGNUS, a cutting-edge head-only magnetic resonance imaging (MRI) scanner. SIGNA MAGNUS is a major advancement that gives scientists a strong instrument to examine the intricacies of the brain in depth. These technologies are crucial for visualizing and understanding brain structure, function, and connectivity in both healthy individuals and those with neurological disorders. Besides this, neuroscience research increasingly leverages AI and machine learning algorithms to analyze large-scale brain imaging and EEG data. These advanced analytical tools enhance the interpretation of complex brain activity patterns, identify subtle biomarkers, and predict disease progression. Also, various organizations are promoting applications of artificial intelligence in brain illnesses in order to provide better diagnostics. For instance, in February 2024, the 10,000 Brains Project, an independent non-profit organization, was launched to promote the ethical application of artificial intelligence (AI) in the battle against Alzheimer's, Parkinson's, and other neurological illnesses. The organization's aim is to provide the leadership, experience, and financial assistance required to ensure that researchers can quickly adopt this powerful new technology in the pursuit of better diagnostics and treatments for patients in need. These factors are further escalating the market demand.
The demand for electroencephalography (EEG) devices is driven by the surging prevalence of epilepsy and sleep disorders. Moreover, magnetoencephalography (MEG) devices are essential for pre-surgical localization of epileptic foci and brain tumor mapping. Apart from this, the increasing incidence of stroke requiring monitoring of cerebral blood flow is bolstering the demand for transcranial doppler devices. Besides this, the demand for intracranial pressure monitors is driven by the rising cases of traumatic brain injury.
High demand in intensive care units (ICUs) for monitoring patients with traumatic brain injury, intracranial hemorrhage, and hydrocephalus is driving the demand for invasive procedures. This procedure is essential for optimizing management during neurosurgical procedures such as tumor resection or placement of shunts. Non-invasive procedures are widely used for diagnosing epilepsy and sleep disorders, and monitoring brain function in stroke, coma, and neurodegenerative diseases. Moreover, it is also utilized in neuroscience research due to accessibility and real-time monitoring capabilities.
According to the brain monitoring market overview, the demand for brain monitoring technologies in the context of specific neurological conditions such as Parkinson's disease, traumatic brain injury (TBI), epilepsy, dementia, and sleep disorders is driven by various clinical needs, advancements in technology, and research initiatives. In Parkinson's disease, there is a high demand for invasive brain monitoring techniques like intraoperative microelectrode recording (MER) and intraoperative macrostimulation (IOM). Moreover, in traumatic brain injury, intracranial pressure (ICP) monitoring is essential to manage elevated ICP levels, which can lead to secondary brain injury post-TBI, guiding treatment strategies, and improving patient outcomes.
According to the brain monitoring market analysis, hospitals use brain monitoring technologies such as CT scans and MRI to quickly diagnose and assess stroke patients. These imaging modalities help determine the type of stroke (ischemic or hemorrhagic) and guide immediate treatment decisions. While neurodiagnostic centers utilize a range of brain monitoring technologies to conduct comprehensive evaluations for patients with complex neurological symptoms. This includes EEG for seizure monitoring, MEG for functional brain mapping, and PET scans for assessing metabolic activity in the brain.
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa.
High adoption of advanced neuroimaging in United States and Canada, technologies such as MRI, CT, and PET scans in hospitals and diagnostic centers are driving the growth in North America region. Moreover, the growth in Europe is driven by a strong focus on neuroscience research, utilizing functional imaging and EEG for understanding brain function and disorders. Apart from this, the rapidly expanding healthcare infrastructure in Asia Pacific with the increasing availability of MRI and CT scans is driving the market growth in the region.